China Biopharma Profit Climbs 20 Percent In H1
This article was originally published in PharmAsia News
Executive Summary
Statistics from the market research agency WIND point out that in the first six months of this year, the accelerated profits of 126 Chinese biopharma companies approached $14.852 billion, jumping 19.98%. Their net profits rose 20.75% to $12.233 billion